Keyword: Coronavirus


Pfizer and BioNTech to Start Omicron Trials

27.01.2022 -

Pfizer and BioNTech are poised to begin their first clinical trial with a new vaccine candidate adapted to offer protection against the Omicron variant of the coronavirus...


US Firms Scramble after Supreme Court Vaccine Vote

20.01.2022 -

In a 6:3 vote, the US Supreme Court has temporarily blocked the Biden administration from implementing its executive order requiring companies with more than 100...


Pfizer/BioNTech Say Booster Works against Omicron

09.12.2021 -

As the most recently documented Covid-19 variant, Omicron, continues to rapidly circle the globe – it has now been found in 57 countries and 21 US states, according to...


Fujifilm to Expand Vaccine Production in UK

06.12.2021 -

Fujifilm Diosynth Biotechnologies is investing £400 million to expand its Teesside site in northeast England, where it makes the active ingredient for the Novavax Covid...


UK’s MHRA Approves Merck & Co Covid Pill

05.11.2021 -

The UK has “pipped the US at the post”, as one commentator noted in typical British colloquialism on the news that the country’s health regulator MHRA has approved the...


Novavax Files for Covid Vaccine Approval in UK

28.10.2021 -

Novavax has completed the submission of real time data to the UK’s Medicines and Health Regulatory Authority for the authorization of its Covid-19 vaccine candidate. It...


Boosters Dominate Covid Vaccine Discussion

19.10.2021 -

Diverse developments taking place simultaneously in Covid-19 vaccines and treatments, especially in the US, are making it difficult for the average market watcher – and...


AstraZeneca Shows FDA Enouraging Antiviral Data

06.10.2021 -

AstraZeneca has provided the US Food and Drug Administration (FDA) with encouraging study evidence that its antiviral cocktail candidate AZD7442 can prevent Covid-19...